Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidance
GlobeNewswire
*PARIS, FRANCE, 24 April 2024 *- Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today..